查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433616

全球口服固體製劑(OSD)契約製造市場規模、佔有率、趨勢分析報告：按產品類型、機制、最終用途、地區和細分市場進行預測 (2024-2030)

Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Product Type (Tablets, Capsules, Powders, Granules), By Mechanism, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 193 Pages | 商品交期: 2-10個工作天內

價格

口服固體製劑（OSD）契約製造市場的成長與趨勢：

預計2030年，全球口服固體製劑契約製造市場規模將達547億美元，2024年至2030年複合年成長率為5.97%。新藥分子複雜性的增加、領先的 CMO 和 CDMO 的研發投資以及對新治療方法的需求不斷成長是推動市場成長的關鍵因素。

口服固態是製藥領域廣泛接受的劑型，因為它們具有成本效益、易於製造且對患者友好。此外，控釋和緩釋性製劑等藥物傳遞技術的進步使口服固態能夠實現更高水平的生物有效性，同時減少給藥頻率。預計這將推動市場成長潛力。

口服固體製劑開發和大規模生產的技術進步是支持這些產品快速商業化的關鍵因素之一。目前市面上有多種劑型。然而，營養補充和製藥食品一直致力於開發 OSD 劑型。原因在於操作簡單、服用方便、病人順從性佳。 OSD 配方技術和材料的進步預計將推動對這些配方的需求。

此外，CMO 和 CDMO 的研發投資有助於增強製造流程、配方開發和分析技術的創新。這可能會導致在口服固體製劑的生產中採用更有效和更先進的製造技術。研發投資還可以提高製造能力並擴充性。這將使 CMO 和 CDMO 能夠提供更大量的口服固體製劑，以滿足製藥公司日益成長的需求。

此外，2023 年該行業也見證了許多策略舉措，包括聯盟、合作夥伴關係、併購和服務擴張。

  • 2023年7月，Aenova集團與Galvita建立策略夥伴關係，以改善口服製劑、生產和開發。
  • 2023 年 4 月，Aenova 投資約 2,196 萬美元（2,000 萬歐元）擴建位於蒂特莫寧的散裝固態工廠，提高產能。
  • 2023 年 1 月，Catalent 和 Ethicann 合作使用 Catalent 的口腔崩解錠(ODT) 技術開發 Ethicann 的臨床藥物管道。

口服固體製劑(OSD)契約製造市場報告亮點

  • 2023年，錠劑細分市場以32.7%的銷售佔有率佔據市場主導地位。錠劑是最常見且首選的 OSD型態，因為其成本效益高、結構緊湊、易於製造且易於自我管理。對雙層片劑的需求不斷增加以及公司擴大配方和控制釋放錠劑生產的投資預計將推動市場成長。
  • 2023年，控制釋放細分市場佔比最大，為52.2%。這種成長歸因於口服控制釋放遞送系統的進步，包括用於精確藥物遞送的生物來源遞送方法，例如圓頂片、雙錠劑、腸貼劑、聚合物奈米系統和外吐小體。因此，對控釋劑型的高需求預計將在不久的將來推動該部門的收益成長。
  • 以最終用途分類，大型企業細分市場所佔佔有率最大，到 2023 年將達到 54.8%。固態製劑製造市場日益受到協作、彈性和高適應性的影響。越來越多的藥物開發公司打算從頭開始設計藥物，並將委託給大型 CMO，從而加速市場成長。此外，擴大聘請專門從事口服固體製劑的CMO，因為他們可以為大型製藥公司帶來好處。
  • 預計亞太地區將在 2023 年引領全球市場，預測期內複合年成長率最快為 6.3%。中國和印度是口服固體製劑契約製造的主要國家，價格明顯較低。此外，新加坡、印度和韓國等亞洲國家因其不斷擴大的製造能力而被認為是製藥業的主要參與者。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章口服固體製劑（OSD）契約製造市場：變數、趨勢、範圍

  • 市場體系展望
  • 市場動態
  • 口服固體製劑(OSD)契約製造市場：分析工具
  • COVID-19 影響分析
  • 口服固體製劑(OSD) 包裝類型分析：泡殼與瓶裝（體積百分比，2022 年）

第4章口服固體製劑（OSD）契約製造市場：細分分析，依產品類型（2018-2030）

  • 口服固體製劑（OSD）契約製造市場：按產品類型分類的要點
  • 口服固體製劑（OSD）契約製造市場：產品類型變化分析
  • 依產品類型

第5章口服固體製劑（OSD）契約製造市場：機制分析

  • 口服固體製劑（OSD）契約製造市場：機制要點
  • 口服固體製劑（OSD）契約製造市場：機制變化分析
  • 按機理

第6章口服固體製劑（OSD）契約製造市場：最終用途分析

  • 口服固體製劑（OSD）契約製造市場：依最終用途分類的要點
  • 口服固體製劑（OSD）契約製造市場：最終用途變化分析
  • 按最終用途

第7章口服固體製劑（OSD）契約製造市場：區域分析

  • 口服固體製劑契約製造（OSD）：市場佔有率分析（2023/2030）
  • 按地區
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭形勢

  • 公司形勢
    • Richter-Helm BioLogics
    • Lonza
    • Catalent, Inc
    • Aenova Group
    • Boehringer Ingelheim International GmbH
    • Jubilant Pharmova Limited
    • Patheon Pharma Services
    • Recipharm AB.
    • Corden Pharma International
    • Siegfried Holding AG
    • Piramal Pharma Solutions
    • AbbVie Contract Manufacturing
    • Next Pharma AB
  • 公司分類
  • 產品/服務熱圖分析
  • 策略舉措
    • 獲得
    • 合作
    • 業務擴展
    • 服務開始
    • 合夥
    • 其他

第 9 章 要點

Product Code: GVR-4-68039-948-4

Oral Solid Dosage Contract Manufacturing Market Growth & Trends:

The global oral solid dosage contract manufacturing market size is expected to reach USD 54.7 billion by 2030 and expand at a CAGR of 5.97% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing complexity of new drug molecules, R&D investments by large CMOs & CDMOs and rising demand for novel therapies are key factors driving market growth.

Oral solids are widely accepted dosage forms in the pharmaceutical sector since they are cost-effective, simple to manufacture, and patient-friendly. Furthermore, advances in drug delivery technology, such as control release and sustained release formation, are enabling oral solids to achieve even higher levels of bioavailability while lowering drug administration frequency. Thereby, it is anticipated to propel market growth potential.

Technological advancements in the development and bulk manufacturing of oral solid dosage forms are among the primary factors supporting the fast-track commercialization of these products. Currently, a diverse array of dosage forms is accessible in the market. However, the nutraceutical and pharmaceutical industries consistently put effort into developing OSD forms. This preference is due to their ease of handling, convenient consumption, and positive patient adherence. Anticipated advancements in technology and materials of OSD forms are projected to boost the demand for these formulations.

Furthermore, R&D investments by CMOs and CDMOs contribute to enhanced innovation in manufacturing processes, formulation development, & analytical technologies. This can lead to the adoption of more efficient and advanced manufacturing techniques in the production of oral solid dosage forms. Also, investments in R&D result in the expansion of manufacturing capabilities and improved scalability. This allows CMOs and CDMOs to offer larger volumes of oral solid dosage production to meet the increasing demand from pharmaceutical companies.

Moreover, the industry witnessed many strategic movements in 2023, such as collaborations, partnerships, M&As, service expansion, etc.

  • In July 2023, Aenova Group and Galvita entered a strategic partnership to improve the formulation, production, and development of oral dosage forms.
  • In April 2023, Aenova invested approximately USD 21.96 million (20 million euros) to expand its high-volume solids site in Tittmoning, resulting in increased capacity.
  • In January 2023, Catalent and Ethicann collaborated to develop Ethicann's clinical drug pipeline using Catalent's technology known as Orally Disintegrating Tablet (ODT) technology.

Oral Solid Dosage Contract Manufacturing Market Report Highlights:

  • The tablets segment dominated the market with a revenue share of 32.7% in 2023. Tablets are the most common and preferred OSD form due to their cost-effectiveness, high compactness, easy manufacturing, and convenience of self-administration. Increased demand for bilayer tablets and investments by firms to expand formulation and controlled-release tablet manufacturing are predicted to drive market growth
  • The controlled release segment accounted for the largest share of 52.2% in 2023. This growth is attributed to advancements in oral controlled release delivery systems, including dome tablets, dual drug tablets, intestinal patches, polymer nanosystems, and bioinspired delivery methods, such as exosomes for precise drug delivery. Thus, high demand for control release dosage forms is anticipated to boost segmental revenue growth in the near future
  • Based on end-use, the large size companies segment accounted for the largest share of 54.8% in 2023. The solid dose manufacturing market is increasingly defined by collaboration, flexibility, and high adaptability. More pharma developers design drugs from the start, intending to outsource them to large CMOs, thereby accelerating market growth. Furthermore, CMOs specializing in oral solid dosage can provide several benefits to large pharmaceutical companies, leading to their increased adoption
  • Asia Pacific led the global market in 2023 and is projected to witness the fastest CAGR of 6.3% during the forecast years. China and India are the powerhouses of oral solid dosage contract manufacturing organizations with significantly lower prices. Further, expanding manufacturing capabilities among Asian countries such as Singapore, India, and South Korea have been considered major players in the pharmaceutical industry due to their expanding manufacturing capabilities

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Regional Scope
    • 1.1.2 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
    • 1.5.1 Region Wise Market Calculation
    • 1.5.2 Region Wise Market: Base Estimates
    • 1.5.3 Global Market: Cagr Calculation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.2 Value-Chain-Based Sizing & Forecasting (Model 2)
    • 1.6.3 Qfd Model Sizing & Forecasting (Model 3)
  • 1.7 Market Formulation & Validation
  • 1.8 Market Definitions/Scope
  • 1.9 List Of Secondary Sources
  • 1.10 List Of Primary Sources
  • 1.11 List Of Abbreviations
  • 1.12 Objectives
    • 1.12.1 Objective - 1
    • 1.12.2 Objective - 2
    • 1.12.3 Objective - 3
    • 1.12.4 Objective - 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Segment Snapshot
  • 2.4 Competitive Landscape Snapshot

Chapter 3 Oral Solid Dosage Contract Manufacturing Market: Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Technological Advancements In Oral Solid Dosage (Osd) Forms
      • 3.2.1.2 Expansion Of Manufacturing Capacity By Cmos & Cdmos For Osd
      • 3.2.1.3 Increasing Demand For Novel Therapies
      • 3.2.1.4 Increasing Demand For One-Stop-Shop Cdmos
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Strict Approval Criteria By Regulatory Authorities
      • 3.2.2.2 Lack Of Experienced Technical Staff, Physical Capability, And Equipment Capacity
      • 3.2.2.3 Increasing Need For Biosimilars And Their Prominence In Addressing Cancer & Other Medical Conditions
  • 3.3 Oral Solid Dosage Contract Manufacturing Market: Analysis Tools
    • 3.3.1 Porter's Five Forces Analysis
    • 3.3.2 Pestel Analysis
  • 3.4 Covid-19 Impact Analysis
  • 3.5 Analysis Pertaining To Oral Solid Dosage Packaging Types, By Blisters Vs. Bottles (Volume % Share, 2022)
    • 3.5.1 Blister Packaging
    • 3.5.2 Bottle Packaging
    • 3.5.3 Types Of Blister Packaging
    • 3.5.4 Blister Packaging

Chapter 4 Oral Solid Dosage Contract Manufacturing Market: Segment Analysis, By Product Type, 2018 - 2030 (USD Million)

  • 4.1 Oral Solid Dosage Contract Manufacturing Market By Product Type: Key Takeaways
  • 4.2 Oral Solid Dosage Contract Manufacturing Market: Product Type Movement Analysis
  • 4.3 Oral Solid Dosage Contract Manufacturing Market Estimates & Forecasts By Product Type (USD Million)
    • 4.3.1 Tablets
      • 4.3.1.1 Tablets Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 4.3.2 Capsules
      • 4.3.2.1 Capsules Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 4.3.3 Powders
      • 4.3.3.1 Powders Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 4.3.4 Granules
      • 4.3.4.1 Granules Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 4.3.5 Others
      • 4.3.5.1 Others Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)

Chapter 5 Oral Solid Dosage Contract Manufacturing Market: Mechanism Analysis

  • 5.1 Oral Solid Dosage Contract Manufacturing Market By Mechanism Segment: Key Takeaways
  • 5.2 Oral Solid Dosage Contract Manufacturing Market: Mechanism Movement Analysis
  • 5.3 Oral Solid Dosage Contract Manufacturing Market Estimates & Forecasts By Mechanism (USD Million)
    • 5.3.1 Immediate Release (IR)
      • 5.3.1.1 Immediate Release Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 5.3.2 Delayed Release
      • 5.3.2.1 Delayed Release Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 5.3.3 Controlled Release (CR)
      • 5.3.3.1 Controlled Release Contract Manufacturing Market, 2018 - 2030 (USD Million)

Chapter 6 Oral Solid Dosage Contract Manufacturing Market: End-Use Analysis

  • 6.1 Oral Solid Dosage Contract Manufacturing Market, By End-Use Segment: Key Takeaways
  • 6.2 Oral Solid Dosage Contract Manufacturing Market: End-Use Movement Analysis
  • 6.3 Oral Solid Dosage Contract Manufacturing Market Estimates & Forecasts By End-Use (USD Million)
    • 6.3.1 Large-Size Companies
      • 6.3.1.1 Large-Size Companies Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 6.3.2 Medium- & Small-Size Companies
      • 6.3.2.1 Medium- & Small- Sized Companies Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 6.3.3 Others
      • 6.3.3.1 Others Contract Manufacturing Market, 2018 - 2030 (USD Million)

Chapter 7 Oral Solid Dosage Contract Manufacturing Market: Regional Analysis

  • 7.1 Oral Solid Dosage Contract Manufacturing: Market Share Analysis, 2023 & 2030
  • 7.2 Oral Solid Dosage Contract Manufacturing: Market Estimates And Forecasts, By Region (USD Million)
  • 7.3 North America
    • 7.3.1 North America Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 7.3.2 U.S.
      • 7.3.2.1 Key Country Dynamics
      • 7.3.2.2 Competitive Scenario
      • 7.3.2.3 Regulatory Scenario
      • 7.3.2.4 U.S. Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3 Canada
      • 7.3.3.1 Key Country Dynamics
      • 7.3.3.2 Competitive Scenario
      • 7.3.3.3 Regulatory Scenario
      • 7.3.3.4 Canada Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4 Europe
    • 7.4.1 Europe Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 7.4.2 Uk
      • 7.4.2.1 Key Country Dynamics
      • 7.4.2.2 Competitive Scenario
      • 7.4.2.3 Regulatory Scenario
      • 7.4.2.4 Uk Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3 Germany
      • 7.4.3.1 Key Country Dynamics
      • 7.4.3.2 Competitive Scenario
      • 7.4.3.3 Regulatory Scenario
      • 7.4.3.4 Germany Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4 France
      • 7.4.4.1 Key Country Dynamics
      • 7.4.4.2 Competitive Scenario
      • 7.4.4.3 Regulatory Scenario
      • 7.4.4.4 France Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5 Italy
      • 7.4.5.1 Key Country Dynamics
      • 7.4.5.2 Competitive Scenario
      • 7.4.5.3 Regulatory Scenario
      • 7.4.5.4 Italy Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6 Spain
      • 7.4.6.1 Key Country Dynamics
      • 7.4.6.2 Competitive Scenario
      • 7.4.6.3 Regulatory Scenario
      • 7.4.6.4 Spain Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7 Denmark
      • 7.4.7.1 Key Country Dynamics
      • 7.4.7.2 Competitive Scenario
      • 7.4.7.3 Regulatory Scenario
      • 7.4.7.4 Denmark Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
    • 7.4.8 Sweden
      • 7.4.8.1 Key Country Dynamics
      • 7.4.8.2 Competitive Scenario
      • 7.4.8.3 Regulatory Scenario
      • 7.4.8.4 Sweden Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
    • 7.4.9 Norway
      • 7.4.9.1 Key Country Dynamics
      • 7.4.9.2 Competitive Scenario
      • 7.4.9.3 Regulatory Scenario
      • 7.4.9.4 Norway Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
  • 7.5 Asia Pacific
    • 7.5.1 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million
    • 7.5.2 China
      • 7.5.2.1 Key Country Dynamics
      • 7.5.2.2 Competitive Scenario
      • 7.5.2.3 Regulatory Scenario
      • 7.5.2.4 China Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3 India
      • 7.5.3.1 Key Country Dynamics
      • 7.5.3.2 Competitive Scenario
      • 7.5.3.3 Regulatory Scenario
      • 7.5.3.4 India Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4 Japan
      • 7.5.4.1 Key Country Dynamics
      • 7.5.4.2 Competitive Scenario
      • 7.5.4.3 Regulatory Scenario
      • 7.5.4.4 Japan Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5 Australia
      • 7.5.5.1 Key Country Dynamics
      • 7.5.5.2 Competitive Scenario
      • 7.5.5.3 Regulatory Scenario
      • 7.5.5.4 Australia Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6 South Korea
      • 7.5.6.1 Key Country Dynamics
      • 7.5.6.2 Competitive Scenario
      • 7.5.6.3 Regulatory Scenario
      • 7.5.6.4 South Korea Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7 Thailand
      • 7.5.7.1 Key Country Dynamics
      • 7.5.7.2 Competitive Scenario
      • 7.5.7.3 Regulatory Scenario
      • 7.5.7.4 Thailand Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6 Latin America
    • 7.6.1 Latin America Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2 Brazil
      • 7.6.2.1 Key Country Dynamics
      • 7.6.2.2 Competitive Scenario
      • 7.6.2.3 Regulatory Scenario
      • 7.6.2.4 Brazil Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3 Mexico
      • 7.6.3.1 Key Country Dynamics
      • 7.6.3.2 Competitive Scenario
      • 7.6.3.3 Regulatory Scenario
      • 7.6.3.4 Mexico Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4 Argentina
      • 7.6.4.1 Key Country Dynamics
      • 7.6.4.2 Competitive Scenario
      • 7.6.4.3 Regulatory Scenario
      • 7.6.4.4 Argentina Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
  • 7.7 MEA
    • 7.7.1 MEA Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
    • 7.7.2 South Africa
      • 7.7.2.1 Key Country Dynamics
      • 7.7.2.2 Competitive Scenario
      • 7.7.2.3 Regulatory Scenario
      • 7.7.2.4 South Africa Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
    • 7.7.3 Saudi Arabia
      • 7.7.3.1 Key Country Dynamics
      • 7.7.3.2 Competitive Scenario
      • 7.7.3.3 Regulatory Scenario
      • 7.7.3.4 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
    • 7.7.4 UAE
      • 7.7.4.1 Key Country Dynamics
      • 7.7.4.2 Competitive Scenario
      • 7.7.4.3 Regulatory Scenario
      • 7.7.4.4 UAE Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.5 Kuwait
      • 7.7.5.1 Key Country Dynamics
      • 7.7.5.2 Competitive Scenario
      • 7.7.5.3 Regulatory Scenario
      • 7.7.5.4 Kuwait Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1. Company Landscape
    • 8.1.1. Richter-Helm BioLogics
      • 8.1.1.1. Company overview
      • 8.1.1.2. Financial performance
      • 8.1.1.3. Product benchmarking
      • 8.1.1.4. Strategic initiatives
    • 8.1.2. Lonza
      • 8.1.2.1. Company overview
      • 8.1.2.2. Financial performance
      • 8.1.2.3. Product benchmarking
      • 8.1.2.4. Strategic initiatives
    • 8.1.3. Catalent, Inc
      • 8.1.3.1. Company overview
      • 8.1.3.2. Financial performance
      • 8.1.3.3. Product benchmarking
      • 8.1.3.4. Strategic initiatives
    • 8.1.4. Lonza
      • 8.1.4.1. Company overview
      • 8.1.4.2. Financial performance
      • 8.1.4.3. Product benchmarking
      • 8.1.4.4. Strategic initiatives
    • 8.1.5. Aenova Group
      • 8.1.5.1. Company overview
      • 8.1.5.2. Financial performance
      • 8.1.5.3. Product benchmarking
      • 8.1.5.4. Strategic initiatives
    • 8.1.6. Boehringer Ingelheim International GmbH
      • 8.1.6.1. Company overview
      • 8.1.6.2. Financial performance
      • 8.1.6.3. Product benchmarking
      • 8.1.6.4. Strategic initiatives
    • 8.1.7. Jubilant Pharmova Limited
      • 8.1.7.1. Company overview
      • 8.1.7.2. Financial performance
      • 8.1.7.3. Product benchmarking
      • 8.1.7.4. Strategic initiatives
    • 8.1.8. Patheon Pharma Services
      • 8.1.8.1. Company overview
      • 8.1.8.2. Financial performance
      • 8.1.8.3. Product benchmarking
      • 8.1.8.4. Strategic initiatives
    • 8.1.9. Recipharm AB.
      • 8.1.9.1. Company overview
      • 8.1.9.2. Financial performance
      • 8.1.9.3. Product benchmarking
      • 8.1.9.4. Strategic initiatives
    • 8.1.10. Corden Pharma International
      • 8.1.10.1. Company overview
      • 8.1.10.2. Financial performance
      • 8.1.10.3. Product benchmarking
      • 8.1.10.4. Strategic initiatives
    • 8.1.11. Siegfried Holding AG
      • 8.1.11.1. Company overview
      • 8.1.11.2. Financial performance
      • 8.1.11.3. Product benchmarking
      • 8.1.11.4. Strategic initiatives
    • 8.1.12. Piramal Pharma Solutions
      • 8.1.12.1. Company overview
      • 8.1.12.2. Financial performance
      • 8.1.12.3. Product benchmarking
      • 8.1.12.4. Strategic initiatives
    • 8.1.13. AbbVie Contract Manufacturing
      • 8.1.13.1. Company overview
      • 8.1.13.2. Financial performance
      • 8.1.13.3. Product benchmarking
      • 8.1.13.4. Strategic initiatives
    • 8.1.14. Next Pharma AB
      • 8.1.14.1. Company overview
      • 8.1.14.2. Financial performance
      • 8.1.14.3. Product benchmarking
      • 8.1.14.4. Strategic initiatives
  • 8.2 Company Categorization
  • 8.3 Product/Service Heat Map Analysis
  • 8.4 Strategy Initiatives
    • 8.4.1 Acquisition
    • 8.4.2 Collaboration
    • 8.4.3 Expansion
    • 8.4.4 Service Launch
    • 8.4.5 Partnership
    • 8.4.6 Others

Chapter 9 Key Takeaways

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Oral Solid Dosage Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 4 North America Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 5 North America Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 8 U.S. Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 10 Canada Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 11 Canada Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe Oral Solid Dosage Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 14 Europe Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 15 Europe Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 UK Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 17 UK Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 18 UK Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Germany Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 20 Germany Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 21 Germany Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 23 France Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 24 France Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 26 Italy Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 27 Italy Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 29 Spain Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 30 Spain Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Denmark Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 32 Denmark Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 33 Denmark Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Sweden Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 35 Sweden Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 36 Sweden Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Norway Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 38 Norway Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 39 Norway Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Oral Solid Dosage Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 China Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 45 China Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 46 China Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 India Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 48 India Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 49 India Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Japan Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million) 2018 - 2030
  • Table 51 Japan Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 52 Japan Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Australia Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 54 Australia Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 55 Australia Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 South Korea Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 57 South Korea Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 58 South Korea Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Thailand Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 60 Thailand Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 61 Thailand Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America Oral Solid Dosage Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 63 Latin America Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 64 Latin America Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 65 Latin America Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Brazil Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million) 2018 - 2030
  • Table 67 Brazil Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 68 Brazil Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Mexico Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 70 Mexico Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 71 Mexico Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Argentina Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 73 Argentina Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 74 Argentina Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 MEA Oral Solid Dosage Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 76 MEA Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 77 MEA Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 78 MEA Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 South Africa Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 80 South Africa Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 81 South Africa Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 UAE Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 86 UAE Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 87 UAE Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Oral solid dosage contract manufacturing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-Chain-Based Sizing & Forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Market formulation & validation
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Parent market outlook, 2023 (USD Million)
  • Fig. 16 Ancillary market outlook, 2023 (USD Million)
  • Fig. 17 Oral solid dosage contract manufacturing market dynamics
  • Fig. 18 Biosimilar approval in the U.S. and EU per year (2016 - 2021)
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 PESTEL analysis
  • Fig. 21 Oral solid dosage packaging types in the U.S., 2023 (volume percentage share %)
  • Fig. 22 Oral solid dosage blister packaging types in the U.S., 2023 (volume percentage share %)
  • Fig. 23 Oral solid dosage contract manufacturing market: Product type outlook and key takeaways
  • Fig. 24 Oral solid dosage contract manufacturing market: Product type movement analysis
  • Fig. 25 Tablets oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 26 Capsules oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 27 Powders oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 28 Granules oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 29 Others oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 30 Oral solid dosage contract manufacturing market: Mechanism outlook and key takeaways
  • Fig. 31 Oral solid dosage contract manufacturing market: Mechanism movement analysis
  • Fig. 32 Immediate release contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 33 Delayed release contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 34 Controlled release contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 35 Oral solid dosage contract manufacturing market: End-use outlook and key takeaways
  • Fig. 36 Oral solid dosage contract manufacturing market: End-use movement analysis
  • Fig. 37 Large-size companies market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 38 Medium- & small- sized companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Others market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 40 Regional market: Key takeaways
  • Fig. 41 Regional outlook, 2023 & 2030
  • Fig. 42 Regional outlook, 2023 & 2030
  • Fig. 43 North America market, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 U.S. Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Canada Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Europe Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 UK Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Germany Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 France Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Italy Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Spain Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Denmark Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Sweden Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Norway Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 China Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Regulatory bodies in India involved in pharmaceutical regulations
  • Fig. 70 India Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Clinical trial authorization process in Japan
  • Fig. 73 Clinical Research of Medical Products in Japan
  • Fig. 74 Japan Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 78 Australia Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Clinical trial approval process in South Korea
  • Fig. 81 South Korea Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Thailand Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Latin America Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Brazil Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Mexico Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Argentina Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 MEA Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 South Africa Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Saudi Arabia Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Clinical trial authorization process UAE
  • Fig. 98 UAE Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Kuwait Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key company categorization
  • Fig. 102 Product/service heat map analysis